14 results were returned
Competition rules are aimed at safeguarding healthy competition between companies. For more than half a century the EU and its Member States have vigorously defended effective competition by pursuing and sanctioning ...
In Belgium, the question arose before the Brussels Court as to whether a foreign company (which was part of an international pharmaceutical group) that only invests in clinical trials and research & development for a ...
The European Commission (EC) has opened a formal investigation into certain alleged excessive pricing practices pursued by Aspen Pharmacare Holdings Limited (Aspen), so-called "price gouging", in relation to off-patent ...
In this article, we touch upon the favorable IP regime, which, provides for specific research exemptions under patent law.
Each Belgian biobank will have to be declared at the Federal Agency for Medicines and Health Products (FAMHP) in order to operate. It also imposes binding content for agreements on the transfer of human biological ...
Last month, the Belgian Parliament voted in favour of a set of measures that are notably meant to clarify the regulatory landscape of the operators active in the manufacturing of Advanced Therapy Medicinal Products ...
International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...
Bird & Bird is delighted to announce that we have received an excellent set of results in the 2018 edition of Legal 500: EMEA. As well as 34 top-tier rankings across our EMEA offices, we were recommended in a further ...
International law firm Bird & Bird today announces the merger of its Baseline consulting arm with Valeocon Management Consulting, creating one of the largest management consultancy firms linked to an international law ...
DEFAULT DEFAULT Most Relevant Alphabetical Chronological Go
REFINE RESULTS: